These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35509846)

  • 1. Cytotoxic Evaluation, Molecular Docking, and 2D-QSAR Studies of Dihydropyrimidinone Derivatives as Potential Anticancer Agents.
    Altaf R; Nadeem H; Ilyas U; Iqbal J; Paracha RZ; Zafar H; Paiva-Santos AC; Sulaiman M; Raza F
    J Oncol; 2022; 2022():7715689. PubMed ID: 35509846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Biological Evaluation, 2D-QSAR, and Molecular Simulation Studies of Dihydropyrimidinone Derivatives as Alkaline Phosphatase Inhibitors.
    Altaf R; Nadeem H; Iqbal MN; Ilyas U; Ashraf Z; Imran M; Muhammad SA
    ACS Omega; 2022 Mar; 7(8):7139-7154. PubMed ID: 35252705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
    Kale MA; Sonwane GM
    Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Some New 1,3,4-Oxadiazole Derivatives and Evaluation of Their Anticancer Activity.
    Yurttaş L; Evren AE; Kubilay A; Aksoy MO; Temel HE; Akalın Çiftçi G
    ACS Omega; 2023 Dec; 8(51):49311-49326. PubMed ID: 38162760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents
    Nemr MTM; AboulMagd AM; Hassan HM; Hamed AA; Hamed MIA; Elsaadi MT
    RSC Adv; 2021 Jul; 11(42):26241-26257. PubMed ID: 35479426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors.
    Srour AM; Ahmed NS; Abd El-Karim SS; Anwar MM; El-Hallouty SM
    Bioorg Med Chem; 2020 Sep; 28(18):115657. PubMed ID: 32828424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinazoline analogues as cytotoxic agents; QSAR, docking, and
    Emami L; Sabet R; Khabnadideh S; Faghih Z; Thayori P
    Res Pharm Sci; 2021 Oct; 16(5):528-546. PubMed ID: 34522200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis,
    Aziz NAAM; George RF; El-Adl K; Mahmoud WR
    RSC Adv; 2022 Apr; 12(20):12913-12931. PubMed ID: 35496328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
    Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
    Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt.
    Abo-Salem HM; Gibriel AA; El Awady ME; Mandour AH
    Med Chem; 2021; 17(2):158-170. PubMed ID: 32141421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
    Davis GD; Vasanthi AH
    Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity, quantitative structure-activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs.
    Miladiyah I; Jumina J; Haryana SM; Mustofa M
    Drug Des Devel Ther; 2018; 12():149-158. PubMed ID: 29391779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II).
    Yılmaz Ö; Bayer B; Bekçi H; Uba AI; Cumaoğlu A; Yelekçi K; Küçükgüzel ŞG
    Med Chem; 2020; 16(6):735-749. PubMed ID: 31203805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents.
    Kadhim ZY; Alqaraghuli HGJ; Abd MT
    Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular properties and comparative docking and QSAR of new 2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetic acid derivatives as possible anticancer agents.
    Elhenawy AA; Al-Harbi LM; El-Gazzar MA; Khowdiary MM; Moustfa A
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Jul; 218():248-262. PubMed ID: 31003050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR and Molecular Docking Studies of Pyrimidine-Coumarin-Triazole Conjugates as Prospective Anti-Breast Cancer Agents.
    Subramani AK; Sivaperuman A; Natarajan R; Bhandare RR; Shaik AB
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhodanine Derivatives as Anticancer Agents: QSAR and Molecular Docking Studies.
    Molnar M; Lončarić M; Opačak-Bernardi T; Glavaš-Obrovac L; Rastija V
    Anticancer Agents Med Chem; 2023; 23(7):839-846. PubMed ID: 36305127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2D- and 3D-QSAR modelling, molecular docking and
    Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
    J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
    Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
    J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.